APA

Marcellin F., Fournier I., Carrieri M. P., Poizot-Martin I. & Cotte L. (20170911). From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials). : European journal of gastroenterology & hepatology.

Chicago

Marcellin Fabienne, Fournier Isabelle, Carrieri Maria P, Poizot-Martin Isabelle and Cotte Laurent. 20170911. From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials). : European journal of gastroenterology & hepatology.

Harvard

Marcellin F., Fournier I., Carrieri M. P., Poizot-Martin I. and Cotte L. (20170911). From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials). : European journal of gastroenterology & hepatology.

MLA

Marcellin Fabienne, Fournier Isabelle, Carrieri Maria P, Poizot-Martin Isabelle and Cotte Laurent. From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials). : European journal of gastroenterology & hepatology. 20170911.